Ryman Healthcare Stock Forecast

Stock Price Forecast

According to 4 analysts polled by S&P Global, Ryman Healthcare stock has a consensus rating of "Buy" and an average price target of $3.01. The average 1-year stock price forecast is 32.02% higher than the current stock price, while the lowest is $2.56 (+12.28%) and the highest is $3.50 (+53.51%).

Price Target: $3.01 (+32.02%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$2.56	$3.01	$2.98	$3.50
Change	+12.28%	+32.02%	+30.70%	+53.51%

Analyst Ratings

The average analyst rating for Ryman Healthcare stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Jan '26	Feb '26	Mar '26	Apr '26	May '26	Jun '26
Strong Buy	1	1	1	3	3	3
Buy	0	0	0	0	0	0
Hold	3	2	3	1	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	4	3	4	4	4	4

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Bianca Fledderus UBS	UBS	Buy Maintains n/a	Buy	Maintains	n/a	n/a	Jun 17, 2026
Unknown Analyst Macquarie No rating	Macquarie	Buy Maintains n/a	Buy	Maintains	n/a	n/a	May 28, 2026
Arie Dekker Jarden	Jarden	Hold Maintains n/a	Hold	Maintains	n/a	n/a	Feb 4, 2026

Financial Forecast

Revenue This Year

946.88M

from 854.47M

10.81%

from 854.47M

Revenue Next Year

1.02B

from 946.88M

7.53%

from 946.88M

EPS This Year

0.12

from -0.17

EPS Next Year

0.18

from 0.12

53.58%

from 0.12

Fiscal Year	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Mar 31, 2022	Mar 31, 2023	Mar 31, 2024	Mar 31, 2025	Mar 31, 2026	Mar 31, 2027
Revenue	508.76M	581.61M	687.56M	759.16M	854.47M	946.88M
Revenue Growth	11.65%	14.32%	18.22%	10.41%	12.55%	10.81%
Gross Profit	42.52M	39.45M	-24.36M	8.07M	80.78M	367.39M
Gross Margin	8.36%	6.78%	-3.54%	1.06%	9.45%	38.80%
Operating Income	6.82M	1.74M	-70.34M	-40.39M	38.22M	196.84M
Net Income	692.87M	257.84M	-169.67M	-513.75M	-171.35M	84.06M
EPS	-	-	-	-	-0.17	0.12
Forward PE	16.49	10.18	11.17	12.14	14.26	19.54
Dividend / Share	0.22	0.09	-	-	-	-
Free Cash Flow	-120.36M	3.88B	318.02M	-5.38B	-96.85M	112.00M
No. Analysts	-	-	-	-	-	3

EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is NZD.

Revenue Forecast

Revenue	2027	2028	2029
High	1.0B
Avg	946.9M
Low	896.6M

Revenue Growth

Revenue Growth	2027	2028	2029
High	20.1%
Avg	10.8%
Low	4.9%

EPS Forecast

EPS	2027	2028	2029
High	0.14
Avg	0.12
Low	0.10

EPS Growth

EPS Growth	2027	2028	2029
High	-
Avg	-
Low	-